Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Charles Wagner, Jr., Stephen Jones, Thomas Kean, Melinda Griffith, and More

Premium

GoodStart Genetics has appointed Charles Wagner, Jr., to its board of directors. Wagner is CFO and executive VP of finance and administration at Bruker Corporation. Previously, he held similar positions at Progress Software Corporatio and Millipore Corporation.


MolecularHealth has added several new members to its advisory board, including Stephen Jones, who from 1999 to 2014 served as the medical director of research for US Oncology Research; Thomas Kean, CEO and president of C-Change, a coalition of stakeholders dedicated to eliminating the cancer burden on the US population; and Kathleen Lokay, president and CEO of Via Oncology.


CardioDx announced that Melinda Griffith will be its new head of corporate development and general counsel and Doug Ross will the firm's new chief scientific officer. Griffith has previously held various executive management positions at Clarient, which was acquired by GE Healthcare. Ross served as acting chief scientific officer of Life Technologies' medical science division.

Simultaneously, CardioDx also appointed James Tobin and Andrew Guggenhime to its board of directors. Tobin was previously CEO of Boston Scientific. Meanwhile, Guggenhime is transitioning currently from his role as CFO at CardioDx to its board of directors.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.